High‐intensity focused ultrasound: Safety and efficacy of a novel treatment modality for neurofibromatosis type 1 cutaneous neurofibroma
Sirkku Peltonen(Varsinais-Suomen Sairaanhoitopiiri), Katrine Karmisholt(Bispebjerg Hospital), Mimmi Tang(Sahlgrenska University Hospital), Karli Rosner(Johns Hopkins University), Noora Neittaanmäki(University of Helsinki), Martin Gillstedt(Sahlgrenska University Hospital), Jaishri O. Blakeley(Johns Hopkins University), Peter Holmström(University of Gothenburg), Joshua Roberts(Johns Hopkins University), Torsten Bove, Jørgen Serup(Bispebjerg Hospital), Despoina Kantere(University of Gothenburg)
Cited by 4
Related Papers
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Review and consensus recommendations on clinical <scp>APT</scp>‐weighted imaging approaches at <scp>3T</scp>: Application to brain tumors
|Magnetic Resonance in Medicine|2022|236
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain
|Magnetic Resonance in Medicine|2007|220
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients
|Tomography|2015|182
A clinical benchmark of public self-supervised pathology foundation models
|Nature Communications|2025|93